3.03 (2.06%)Mean Reversion
Neutral
Trend
Very Strong
Event
Neutral
Mqv
Very Weak
Garp
Very Weak
Mqv Small
Very Weak
Value
Consensus
Price
Very Strong
Earnings
Very Weak
Earnings
Very Weak
Dividends
Very Weak
Capital Efficiency
Very Weak
Balance Sheet
Strong
Website
Revolution Medicines, Inc.
Telephone
1.650.481.6801
Address
700 Saginaw Drive, Redwood City, CA 94063
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 34 - 155.7
Trade Value (12mth)
US$55,441,799.00
1 week
1.13%
1 month
-1.07%
YTD
86.41%
1 year
280.23%
All time high
155.70
EPS 3 yr Growth
92.90%
EBITDA Margin
0.00%
Operating Cashflow
-$898m
Free Cash Flow Return
-40.50%
ROIC
-51.10%
Interest Coverage
-48.10
Quick Ratio
7.10
Shares Outstanding (Fully Diluted)
198m
HALO Sector
Healthcare
Next Company Report Date
01-Mar-27
Next Ex Dividend Date
N/A
Next Dividend Pay Date
N/A
Reporting Currency
USD
Short Sell (% of issue)
0.00
| Date | Announcements |
| 07 May 26 | |
| 07 May 26 | |
| 07 May 26 | |
| 07 May 26 | |
| 18 April 26 |
Historical data
Forecast data
| USD | 2021 | 2022 | 2023 | 2024 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |||
| Per Share, Growth & Valuations | |||||||||||||
EPS (Basic) | $ |  | | | | -3.86 | -3.58 | -5.95 | | | | ||
EPS (Fully Diluted) | $ | | | | | -3.86 | -3.58 | -5.95 | | | | ||
Growth | % | | | | | -25 | 7.2 | -66.3 | | | | ||
PE | X | | | | | N/A | N/A | N/A | | | | ||
EV/EBITDA | X | | | | | N/A | N/A | N/A | | | | ||
Ex Dividend Date (est.)
DIV Yield
Franking Level
DPSg
Quality Yield
Falling Divs over next 2
Consensus Score
Recommendation
EPS 1 month Change
Quality Yield
Falling Divs over next 2
